Background/Aims: It has been implicated that calcium supplementation is involved in reducing body weight/fat and improving glucose homeostasis. However, the underlying mechanisms are still not fully understood. Here, we investigated the effects of calcium supplementation on adipogenesis and glucose homeostasis in porcine bone marrow mesenchymal stem cells (pBMSCs) and high fat diet (HFD)-fed mice and explored the involved signaling pathways. Methods: In vitro, pBMSCs were treated with 4 mM extracellular calcium ([Ca 2+ ] o ) and/or 1 μM nifedipine, 0.1 μM BAPTA-AM, 1 μM KN-93, 50 nM wortmannin for 10 days. The intracellular calcium ([Ca 2+ ] i ) levels were measured using Fluo 3-AM by flow cytometry. The adipogenic differentiation of pBMSCs was determined by Oil Red-O staining and triglyceride assay. The expression of marker genes involved in adipogenesis (peroxisome proliferator activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα)) and glucose uptake (glucose transporter 4 (GLUT4)), as well as the activation of Ca 2+ /calmodulin-dependent In vivo, calcium supplementation decreased body weight and fat content, increased adipocyte number, and improved glucose homeostasis, with elevated PPARγ and GLUT4 expression and PI3K/Akt activation in iWAT. Conclusion: calcium supplementation enhanced adipogenesis and glucose uptake in pBMSCs, which was coincident with the increased adipocyte number and improved glucose homeostasis in HFD-fed mice, and was associated with activation of CaMKII and PI3K/Akt-FoxO1/AS160 pathways. These data provided a broader understanding of the mechanisms underlying calcium-induced body weight/fat loss and glycemic control.
Introduction
Obesity, a major risk factor for the development of insulin resistance, type 2 diabetes and cardiovascular diseases, has been a pandemic and serious public health challenge worldwide [1] . Although the expanded fat mass can result from the increased adipocyte size (hypertrophy) and/or increased adipocyte number (hyperplasia or adipogenesis) [2] , it has been demonstrated that hypertrophic adipose expansion is associated with obesity and impaired insulin sensitivity while hyperplasic adipose expansion or adipogenesis is linked to anti-obesity and improved insulin sensitivity [3] [4] [5] . Thus, stimulation of adipocyte hyperplasia or adipogenesis may contribute to prevention of obesity, insulin resistance and type 2 diabetes.
Adipogenesis is a complicated process which includes the commitment of mesenchymal stem cells (MSCs) to the adipocyte lineage (preadipocytes) and the terminal differentiation of preadipocytes to mature adipocytes. This process is tightly regulated by various signaling molecules and several key adipogenic transcription factors such as peroxisome proliferator activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) [6] . During adipogenesis, triglyceride (TG) is accumulated in the adipocytes through lipogenesis [7] . The de novo lipogenesis in adipose tissue is affected by the expression, translocation of glucose transporter 4 (GLUT4) and glucose uptake, and exerts beneficial effects on insulin sensitivity [4, 8] . Pigs have been widely used as valuable models in biomedical research because of their similar structure and function to those of humans [9] . Thus, the porcine bone marrow MSCs (pBMSCs) were selected for the in vitro studies in the present study.
It has been demonstrated that calcium is involved in the adipogenesis of 3T3-L1 cells [10] , human preadipocytes [11] , and mice BMSCs [12] . However, calcium has quite different, even opposite effects on adipogenesis, depending upon the various cell types. In addition, calcium also plays an important role in regulating glucose uptake in the isolated working rat heart [13] , mice skeletal muscle [14] , and 3T3-L1 cells [15] . Moreover, dietary calcium has been confirmed to elicit beneficial effects on body weight/fat reduction and glycemic control [16] [17] [18] . Although the increase of fat oxidation and fecal fat excretion [19] , the elevation of adipose tissue apoptosis [20] , and the gut microbiota [16, 21] have been implicated to be partly involved, the mechanisms by which calcium modulates body weight/fat and glucose homeostasis are still not fully understood.
Thus, this study was designed to investigate the effects of calcium supplementation on adipogenesis and glucose homeostasis in pBMSCs and mice fed HFD and explore the signaling pathways involved in this process. Our data showed that calcium supplementation enhanced adipogenesis and glucose uptake in pBMSCs, and increased adipocyte number, improved glucose tolerance and insulin sensitivity in HFD-fed mice through activation of Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) and PI3K/Akt signaling pathway, which might contribute to the reduction of body weight/fat and improvement of glucose homeostasis.
Materials and Methods

Chemicals and antibodies
Calcium acetate, calcium chloride, Nifedipine (a selective inhibitor of L-type voltage-gated calcium channels, L-VGCC), calcium indicator Fluo-3 AM, BAPTA-AM (a selective chelator of intracellular calcium), insulin, dexamethasone, oleic acid, octanoic acid, KN-93 (a CaMKII inhibitor), 2-NBDG (a fluorescent glucose analogue) and Oil Red O were purchased from Sigma-Aldrich. Wortmannin (WT, a PI3K/Akt inhibitor) was purchased from Beyotime Biotechnology. DMEM/F12 and fetal bovine serum (FBS) were purchased from Gibco BRL. Antibodies against PPARγ, C/EBPα, phospho-PI3K p85α (Tyr508), Akt, phospho-Akt (Thr308), FoxO1 and phospho-FoxO1 (Ser256), AS160, phospho-AS160 (Thr642) were purchased from Cell Signaling Technology Inc. Antibodies against β-actin, GLUT4, PI3K p85α and CaMKII were purchased from Bioss Inc. Antibodies against aP2 and phospho-CaMKII (Thr286) were purchased from Santa Cruz Biotechnology, Inc..
Cell culture and treatment
pBMSCs were isolated and purified from the bone marrow of postnatal Landrace pigs aged of 5 to 7 days as previously described [22] . The purified pBMSCs were seeded in a 6-well plate with density of 300, 000 cells/well and cultured in DMEM/F12 medium (containing 1 mM calcium) with 10% (v/v) FBS. Two days post-confluence, cells were switched to differentiation medium (DMEM/F12 supplemented with 50 nM insulin, 50 nM dexamethasone, 50 μM oleic acid，0.5 mM octanoic acid, 5% FBS, 100 U/mL of penicillin sodium and 100 μg/L of streptomycin sulfate). During the adipogenic differentiation, the pBMSCs were ] o -mediated adipogenesis and glucose uptake in pBMSCs, respectively.
Oil Red-O staining and Triglyceride (TG) assay
Lipid accumulation and TG contents in the differentiated pBMSCs were determined by Oil Red O staining and a TG assay kit (Applygen Technologies Inc, China) as previously described [5, 23] .
Glucose uptake and utilization assay
Glucose uptake into the differentiated pBMSCs was measured using 2-NBDG as previously described with a Synergy 2 Multi-Mode Reader (Bio-Tek, USA) [5] . Glucose utilization of the differentiated pBMSCs were determined using glucose content assay kit (Applygen Technologies Inc, China) as previously described [24] .
Measurements of [Ca
] i levels of pBMSCs were measured using Fluo 3-AM by flow cytometry as previously described [25] .
Animal and in vivo study
Twenty-eight C57BL/6J male mice (4-week-old) were purchased from Guangdong Medical Laboratory Animal Center and housed in environmentally controlled rooms on a 12-h light-dark cycle (light from 08:00 to 20:00) with free access to food and water. After 5 days of acclimation, the mice were randomly divided into the HFD group (n=15) and HFD+Ca and food intake were recorded weekly. After treatment for 13 weeks, the body fat content and body fat distribution were determined by using Small Animal Body Composition Analysis and Imaging System NMR Analyzer (MesoQMR23-060H, Niumag Corporation, Shanghai, China). The mice were sacrificed by carbon dioxide anesthesia. The blood was collected for determination of blood glucose and serum insulin levels. Meanwhile, the inguinal white adipose tissue (iWAT) and epidydimal WAT (eWAT) were collected, weighed, and used for further analysis. All animal experiments were conducted with the permission number of SYXK (Guangdong) 2014-0136, and animal care procedures were performed in accordance with the guidelines for the care and use of animals approved by The Animal Ethics Committee of South China Agricultural University.
H&E staining, adipocyte diameter and adipocyte number analysis
The paraffin-embedded iWAT sections were stained with H&E as previously described [23] . Adipocyte diameter and adipocyte number analysis was performed as previously described [5] .
Oral glucose tolerance test (OGTT) and intraperitoneal insulin tolerance test (ITT)
After the mice were treated for 10 weeks, OGTT and ITT were performed as previously described [5] .
Western blot analysis
The protein of pBMSCs and iWAT was extracted and Western blot analysis was performed as previously described [25] . We used anti-PPARγ 
Statistical Analysis
All data are presented as means ± standard error of the mean (S.E.M.). Statistical analysis was performed using SigmaPlot 12.5 (Systat Software, Inc., San Jose, CA). Differences between means were determined using two-tailed Student's t-test and a confidence level of P < 0.05 was considered to be statistically significant. ] o significantly stimulated pBMSCs adipogenesis, with elevated protein expression of adipogenic marker genes such as PPARγ, C/EBPα, and aP2 (Fig. 1C, D) ] o was reversed by L-VGCC blocker Nifedipine ( Fig. 2A, B) . Furthermore, Nifedipine completely abolished the promotion of lipid accumulation induced by 4 mM [Ca 2+ ] o in pBMSCs (Fig. 2C, D) . In agreement, the [Ca 2+ ] o -induced increase of PPARγ, CEBPα, and aP2 expression was eliminated by Nifedipine (Fig. 2E, F In the upper left image, the x axis is the forward scatter area (FSC-A) and the y axis is the side scatter area (SSC-A).
Results
L-VGCC
In the bottom left image, the x axis is the forward scatter area (FSC-A) and the y axis is fluorescein isothiocyanate area (FITC-A). In the upper right image, the x axis is fluorescein isothiocyanate area (FITC- In the upper left image, the x axis is the forward scatter area (FSC-A) and the y axis is the side scatter area (SSC-A).
In the bottom left image, the x axis is the forward scatter area (FSC-A) and the y axis is fluorescein isothiocyanate area (FITC-A). In the upper right image, the x axis is fluorescein isothiocyanate area (FITC- Cellular Cellular ] o -induced pBMSCs adipogenesis, Wortmannin (WT), a PI3K inhibitor, was applied to inhibit PI3K/Akt in the present study. As shown in Fig. 6A ] o -induced increase of p-PI3K/PI3K, p-Akt/Akt and p-FoxO1/ FoxO1 ratios (Fig. 6C, D) . Furthermore, the elevated expression of PPARγ, CEBPα, and aP2 in response to 4 mM [Ca 2+ ] o was fully eliminated by WT (Fig. 6C, D) . These findings strongly suggested that the enhancement of PI3K/Akt-FoxO1 signaling pathway was responsible for the [Ca 2+ ] o -stimulated pBMSCs adipogenesis.
[Ca 2+ ] o increased glucose uptake and utilization, GLUT4 expression and translocation through activation of CaMKII-PI3K/Akt-AS160 pathway
We also examined the effects of [Ca 2+ ] o on glucose uptake and utilization during pBMSCs adipogenesis. The result of 2-NBDG uptake assay showed that [Ca 2+ ] o significantly increased glucose uptake in the differentiated pBMSCs (Fig. 7A) . Meanwhile, the glucose utilization ] o induced remarkable elevation of glucose utilization (Fig. 8) . In agreement with the [ Ca   2+ ] o -induced increase of glucose uptake and utilization, we found that [Ca 2+ ] o significantly enhanced GLUT4 expression ( Fig. 5 and Fig. 6C, D) and translocation, with a significant increase of membrane GLUT4 expression and a remarkable decrease of cytoplasm GLUT4 expression in the differentiated pBMSCs (Fig. 7B-G) . Furthermore, the phosphorylation level of AS160 (a substrate of Akt) in the differentiated pBMSCs was elevated by [Ca 2+ ] o (Fig. 5 and Fig. 6C, D) . However, the increases of glucose uptake and utilization, the stimulation of GLUT4 expression and translocation, and the elevation p-AS160/AS160 ratio were abolished by L-VGCC blocker Nifedipine, [Ca 2+ ] i chelator BAPTA-AM, CaMKII inhibitor KN-93, and PI3K inhibitor WT (Fig.  6, Fig. 7 and Fig. 8 ). These results suggested that calcium influx via L-VGCC, elevation of 
Calcium supplementation decreased body weight and fat content, while increased adipocyte number of iWAT in mice fed HFD
We further explored the effects of calcium supplementation on adipogenesis in mice fed HFD by determining the adipocyte number in iWAT. In this study, we found that calcium ] o . Culture medium were changed every other day and were collected on days 2, 4, 6, 8 and 10 of differentiation. Meanwhile, the adipogenic medium without cells (un-culture medium) were also incubated and collected on the same day. Glucose utilization of cells was determined by subtracting the glucose content of the culture medium from that of the un-culture medium. The glucose contents were normalized to the corresponding protein content of cells. (Fig. 9A) , with no effect on the average food intake (data not shown). Meanwhile, QMR results revealed that calcium supplementation led to a significant reduction of body fat content ( Fig. 9B and C) . Accordingly, the iWAT and eWAT index was also markedly decreased by calcium supplementation (Fig.  9D ). In addition, H&E staining results showed that calcium supplementation resulted in the smaller adipocyte size (Fig. 9E) , with the significant reduced average diameter in iWAT (Fig. 9F) . Inspection of the diameter distribution indicated that diameter of most adipocytes (about 75%) in the HFD group was in the range of 40-100 μm. In contrast, diameter of most adipocytes (about 85%) in the calcium-supplemented group was in the range of 20-60 μm (Fig. 9H) . Based on the average diameter of adipocyte in iWAT and the weight of iWAT, we calculated the total number of adipocytes in iWAT. Interestingly, our results demonstrated that calcium supplementation significantly increased adipocyte number in iWAT (Fig. 9G) , suggesting that calcium supplementation enhanced adipogenesis or hyperplasia in mice iWAT.
Calcium supplementation improved glucose homeostasis, enhanced PPARγ and GLUT4 expression, and activated PI3K/Akt signaling pathway
To further investigate the effects of calcium supplementation on glucose homeostasis in vivo, we measured the blood glucose and serum insulin levels, and evaluated glucose tolerance and insulin sensitivity by performing OGTT and ITT in mice. As shown in Fig.  10A and B, blood glucose and serum insulin levels were significantly decreased in calcium- 
PI3K/Akt
supplemented mice. In addition, calcium-treated mice exhibited improved glucose tolerance compared with HFD mice (Fig. 10C and D) . Similarly, calcium-treated mice showed increased insulin sensitivity compared with HFD mice (Fig. 10E and F) . Thus, our results indicated that calcium supplementation improved glucose homeostasis in mice fed HFD.
In consistent with the elevated adipocyte number or enhanced adipogenesis, and the improved glucose homeostasis induced by calcium supplementation, we found that calcium treatment significantly increased the expression of PPARγ and GLUT4 (Fig. 10G and H) . Meanwhile, the ratios of p-PI3K/PI3K and p-Akt/Akt were markedly elevated by calcium treatment, indicating the activation of PI3K/Akt signaling pathway. These results suggested that activation of PI3K/Akt signaling pathway and subsequent enhanced expression of PPARγ and GLUT4 in iWAT might be involved in the increased adipocyte number and improved glucose homeostasis induced by calcium supplementation.
Discussion
In this paper, our results demonstrated that calcium supplementation enhanced adipogenesis and glucose uptake in pBMSCs, as well as increased adipocyte number and improved glucose tolerance and insulin sensitivity in HFD-fed mice, which might contribute to the calcium-induced body weight/fat reduction and glucose homeostasis improvement. It has been indicated that high [Ca 2+ ] o (9 mM) enhances adipocyte accumulation in mice BMSCs [12, 26] and that 5 mM [Ca 2+ ] o stimulates adipogenesis of porcine synovium-derived MSCs [27] . In line with these results, we found that [Ca 2+ ] o (4 mM) significantly promoted pBMSCs adipogenesis through increasing the expression of adipogenic marker genes such as PPARγ, C/EBPα, and aP2. However, it has also been reported that high [Ca 2+ ] o (5 and 10 mM) attenuated adipogenesis in 3T3-L1 preadipocytes by inhibiting the expression of PPARγ and C/EBPα [28] . The inconsistent effects of [Ca 2+ ] o on adipogenesis were probably due to the different cell types and culture systems.
In agreement with the enhanced adipogenesis in pBMSCs, we found that calcium supplementation stimulated adipogenesis in mice fed HFD, with increased adipocyte number and PPARγ expression in iWAT. Similarly, dietary calcium propionate supplementation in finishing steers triggered upregulation of PPARγ mRNA expression level, which could cause long-term activation of adipogenesis [29] . Although the adipocyte number is increased, the adipocyte diameter/size in calcium-supplemented mice was much smaller than that of HFD mice. As a result, the WAT index, body fat content and body weight were significantly reduced by calcium supplementation, which was in line with the body weight/fat-lowering effects of calcium supplementation in the dietary obese mice [20, 21, 30] and human [31] . In contrast, it was also reported that increasing dairy calcium intake had no effect on decreasing body weight/fat of adolescent girls [32] . The discrepancy effects of calcium on body weight/fat loss might result from the different subjects, calcium intake amounts, and calcium intake periods.
It has been indicated that L-VGCC, an important calcium influx channel in the plasma membrane, is involved in [Ca 2+ ] o -mediated adipogenesis of mice primary preadipocytes [33] . Similarly, we found that L-VGCC blocker Nifidipine prevented the increase of [Ca ] i was found to promote adipogenesis of mice BMSCs [12, 26] and to boost the late stage of differentiation and lipid filling in human adipocyte differentiation [34] . Conversely, it was shown that chelation of [Ca 2+ ] i with BAPTA-AM caused a dramatic increase of adipogenesis in L7 cells [35] . The differences of cell types and culture system likely in part contributed to the discrepancies between the aforementioned studies.
CaMKII ] o -stimulated pBMSCs adipogenesis. Consistently, Szabo et al. reported a significant decrease of lipid accumulation and lower expression of adipogenic marker genes upon CaMKII inhibition in L7 cells [35] . Thus, our results strongly suggested that activation of CaMKII was involved in [Ca 2+ ] o -stimulated pBMSCs adipogenesis. The PI3K/Akt-FoxO1 signaling pathway plays a crucial role in the regulation of adipogenesis by enhancing the expression of adipogenic genes PPARγ and C/EBPα [37] . To be in accord, we found that [Ca ] o -stimulated pBMSCs adipogenesis. Besides the regulatory effects on adipogenesis, calcium has also been implicated in the modulation of glucose uptake in 3T3-L1 cells [15] . In consistent, we found that [Ca 2+ ] o profoundly stimulated the 2-NBDG uptake and glucose utilization in the differentiated pBMSCs. Meanwhile, our results showed that calcium supplementation significantly reduced blood glucose and serum insulin levels, and improved glucose tolerance and insulin sensitivity in HFD-fed mice. Similarly, the beneficial effects of dietary calcium on glycemic control has been indicated in many studies [16, 18, 38] . However, consumption of high calcium provided no effect on glycemic control in overweight patients with type 2 diabetes [17] .
It has been well defined that PI3K/Akt signaling plays a key role in the regulation of glucose uptake [39] , which involves the phosphorylation of AS160 [40] and translocation of GLUT4. In this study, we observed that [Ca 2+ ] o led to the enhancement of PI3K/Akt activation, AS160 phosphorylation, and GLUT4 expression and translocation from cytoplasm to cell membrane in the differentiated pBMSCs. Meanwhile, calcium supplementation activated PI3K/Akt and enhance GLUT4 expression in mice iWAT. In addition, the [Ca 2+ ] o -stimulated of glucose uptake/utilization, AS160 phosphorylation, and GLUT4 expression and translocation were completely blocked by the PI3K inhibitor Wortmannin. Similarly, it was reported that PI3K/ Akt was also involved in ursolic acid-stimulated AS160 phosphorylation, GLUT4 expression and translocation, and glucose uptake in 3T3-L1 adipocytes [41] . Moreover, we observed that PI3K/Akt-mediated AS160 phosphorylation, GLUT4 expression and translocation, and glucose uptake were also eliminated by L-VGCC inhibitor nifedipine, [Ca 2+ ] i chelator BAPTA-AM, and CaMKII inhibitor KN-93, suggesting the essential role of L-VGCC, [Ca 2+ ] i and CaMKII in this process. Similarly, it was reported that rutin-induced glucose uptake in rat soleus muscle was blunted by nifedipine and KN-93 [42] . At the same time, chelation of [Ca 2+ ] i with BAPTA-AM resulted in the inhibition of insulin-stimulated GLUT4 translocation and glucose uptake in 3T3-L1 cells [15] . Together, these data implied that [Ca 2+ ] o influx through L-VGCC, elevation of [Ca 2+ ] i , activation of CaMKII and subsequent enhancement of PI3K/Akt-AS160 signaling cascade might be responsible for [Ca 2+ ] o -induced GLUT4 translocation and glucose uptake in the differentiated pBMSCs and improved glucose homeostasis in HFD-fed mice.
Conclusion
Our findings suggested that calcium supplementation enhanced adipogenesis and glucose uptake in pBMSCs, which was coincident with the increased adipocyte number and improved glucose homeostasis in HFD-fed mice, and was associated with activation ] i , activating CaMKII and PI3K/Akt, and enhancing PPARγ and GLUT4 expression and GLUT4 translocation. In vivo, calcium supplementation decreased body weight and fat content, increased adipocyte number in iWAT, and improved glucose tolerance and insulin sensitivity, with elevated PPARγ and GLUT4 expression and PI3K/Akt activation. of CaMKII and PI3K/Akt-FoxO1/AS160 signaling pathway (Fig. 11) . These data provide a broader understanding of the mechanisms underlying dietary calcium-induced body weight loss and glycemic control and help to develop nutritional intervention/therapy strategies for obesity, insulin resistance and related type 2 diabetes.
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